JP2011502954A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502954A5
JP2011502954A5 JP2009544272A JP2009544272A JP2011502954A5 JP 2011502954 A5 JP2011502954 A5 JP 2011502954A5 JP 2009544272 A JP2009544272 A JP 2009544272A JP 2009544272 A JP2009544272 A JP 2009544272A JP 2011502954 A5 JP2011502954 A5 JP 2011502954A5
Authority
JP
Japan
Prior art keywords
polar
composition
residues
activity
aliphatic non
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009544272A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502954A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/088979 external-priority patent/WO2008083239A2/en
Publication of JP2011502954A publication Critical patent/JP2011502954A/ja
Publication of JP2011502954A5 publication Critical patent/JP2011502954A5/ja
Pending legal-status Critical Current

Links

JP2009544272A 2006-12-27 2007-12-27 免疫応答を刺激する組成物および方法 Pending JP2011502954A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87731906P 2006-12-27 2006-12-27
US94974207P 2007-07-13 2007-07-13
PCT/US2007/088979 WO2008083239A2 (en) 2006-12-27 2007-12-27 Compositions and methods for stimulating an immune response

Publications (2)

Publication Number Publication Date
JP2011502954A JP2011502954A (ja) 2011-01-27
JP2011502954A5 true JP2011502954A5 (enExample) 2011-03-10

Family

ID=39521467

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2009544272A Pending JP2011502954A (ja) 2006-12-27 2007-12-27 免疫応答を刺激する組成物および方法
JP2009544267A Expired - Fee Related JP5481199B2 (ja) 2006-12-27 2007-12-27 炎症および自己免疫疾患を治療するための組成物および方法
JP2013103888A Expired - Fee Related JP5926701B2 (ja) 2006-12-27 2013-05-16 炎症および自己免疫疾患を治療するための組成物および方法
JP2015229316A Withdrawn JP2016035474A (ja) 2006-12-27 2015-11-25 炎症および自己免疫疾患を治療するための組成物および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2009544267A Expired - Fee Related JP5481199B2 (ja) 2006-12-27 2007-12-27 炎症および自己免疫疾患を治療するための組成物および方法
JP2013103888A Expired - Fee Related JP5926701B2 (ja) 2006-12-27 2013-05-16 炎症および自己免疫疾患を治療するための組成物および方法
JP2015229316A Withdrawn JP2016035474A (ja) 2006-12-27 2015-11-25 炎症および自己免疫疾患を治療するための組成物および方法

Country Status (6)

Country Link
US (4) US20080206235A1 (enExample)
EP (3) EP2586458B1 (enExample)
JP (4) JP2011502954A (enExample)
AU (2) AU2007339773B2 (enExample)
CA (2) CA2673659A1 (enExample)
WO (2) WO2008083228A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1224623A (en) * 1984-06-22 1987-07-28 Koichi Usui Synthetic fraipontite and process for preparation thereof
WO2002010187A1 (en) 2000-07-27 2002-02-07 Mayo Foundation For Medical Education And Research B7-h3 and b7-h4, novel immunoregulatory molecules
US7989173B2 (en) * 2006-12-27 2011-08-02 The Johns Hopkins University Detection and diagnosis of inflammatory disorders
CA2673659A1 (en) * 2006-12-27 2008-07-10 The Johns Hopkins University Methods of detecting and diagnosing inflamatory responses and disorders by determining the level of soluble b7-h4
US20090142342A1 (en) * 2006-12-27 2009-06-04 Johns Hopkins University B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
KR101429013B1 (ko) * 2007-07-02 2014-08-11 삼성전자주식회사 도전성 전사 롤러의 제조방법, 이로부터 제조된 전사롤러및 이를 포함하는 화상형성장치
US8475785B2 (en) 2008-03-03 2013-07-02 The University Of Miami Allogeneic cancer cell-based immunotherapy
WO2010030643A1 (en) * 2008-09-10 2010-03-18 Indiana University Research And Technology Corporation Diagnosis and prognosis of immune disorders using stat4 expression
JP5883384B2 (ja) 2009-08-13 2016-03-15 ザ ジョンズ ホプキンス ユニバーシティー 免疫機能を調節する方法
US9005616B2 (en) 2009-08-31 2015-04-14 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection
WO2012145568A1 (en) 2011-04-21 2012-10-26 Albert Einstein College Of Medicine Of Yeshiva University Antibodies to human b7x for treatment of metastatic cancer
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
CA2845536A1 (en) 2011-08-15 2013-02-21 Amplimmune, Inc. Anti-b7-h4 antibodies and their uses
EP2934575A2 (en) * 2012-12-19 2015-10-28 Amplimmune, Inc. B7-h4 specific antibodies, and compositions and methods of use thereof
AU2014265142A1 (en) 2013-05-17 2015-12-24 Medimmune, Llc Receptors for B7-H4
WO2014194293A1 (en) 2013-05-30 2014-12-04 Amplimmune, Inc. Improved methods for the selection of patients for pd-1 or b7-h4 targeted therapies, and combination therapies thereof
MX2017011644A (es) 2015-03-13 2017-12-04 Cytomx Therapeutics Inc Anticuerpos anti-pdl1, anticuerpos anti-pdl1 activables y metodos de uso de los mismos.
SI3370768T1 (sl) 2015-11-03 2022-04-29 Janssen Biotech, Inc. Protitelesa, ki se specifično vežejo na PD-1, in njihove uporabe
EP3630838A1 (en) 2017-06-01 2020-04-08 CytomX Therapeutics, Inc. Activatable anti-pdl1 antibodies, and methods of use thereof
UA128472C2 (uk) 2017-08-25 2024-07-24 Файв Прайм Терапеутікс Інк. B7-h4 антитіла і методи їх використання
US12398209B2 (en) 2018-01-22 2025-08-26 Janssen Biotech, Inc. Methods of treating cancers with antagonistic anti-PD-1 antibodies
KR20200112913A (ko) 2018-01-23 2020-10-05 넥스트큐어 인코포레이티드 B7-h4 항체 및 그 사용 방법
BR112020016986A2 (pt) 2018-02-21 2021-03-02 Five Prime Therapeutics, Inc. formulações de anticorpo contra b7-h4
CA3091801A1 (en) 2018-03-02 2019-09-06 Five Prime Therapeutics, Inc. B7-h4 antibodies and methods of use thereof
US20190345246A1 (en) * 2018-05-10 2019-11-14 TympoBio, Inc. Compositions and Methods for Treating Autoimmune Inner Ear Disease
KR20230137339A (ko) 2021-01-04 2023-10-04 메르사나 테라퓨틱스, 인코포레이티드 B7h4-표적화된 항체-약물 접합체 및 이의 사용 방법

Family Cites Families (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202587A (en) * 1878-04-16 Improvement in door-hangers
US36107A (en) * 1862-08-05 Improvement in
US12758A (en) * 1855-04-24 chane
GB1268212A (en) * 1968-04-19 1972-03-22 Zaidan Hojin Biseibutsu Tripeptide derivatives
JPS6050743B2 (ja) * 1976-06-02 1985-11-09 旭光学工業株式会社 アパタイト焼結体及びその製造方法
US4272398A (en) * 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5155020A (en) 1989-03-08 1992-10-13 Health Research Inc. Recombinant poxvirus host range selection system
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
CH652145A5 (de) 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4634666A (en) * 1984-01-06 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Human-murine hybridoma fusion partner
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4861719A (en) * 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US4925673A (en) * 1986-08-18 1990-05-15 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
US5260203A (en) * 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
EP0832981A1 (en) 1987-02-17 1998-04-01 Pharming B.V. DNA sequences to target proteins to the mammary gland for efficient secretion
US4853871A (en) 1987-04-06 1989-08-01 Genex Corporation Computer-based method for designing stablized proteins
US4980289A (en) * 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US5278056A (en) * 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US4891719A (en) * 1988-10-03 1990-01-02 Datatape Incorporated Fast closure method for a data signal channel
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5225336A (en) 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
US5175099A (en) 1989-05-17 1992-12-29 Research Corporation Technologies, Inc. Retrovirus-mediated secretion of recombinant products
US5240846A (en) 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5204243A (en) * 1990-02-14 1993-04-20 Health Research Incorporated Recombinant poxvirus internal cores
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
AU665190B2 (en) 1990-07-10 1995-12-21 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5770429A (en) * 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5789650A (en) * 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
DE69230142T2 (de) * 1991-05-15 2000-03-09 Cambridge Antibody Technology Ltd. Verfahren zur herstellung von spezifischen bindungspaargliedern
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
US5120727A (en) 1991-05-29 1992-06-09 American Home Products Corporation Rapamycin dimers
DE69228606T2 (de) 1991-07-03 1999-06-24 Kanebo, Ltd., Tokio/Tokyo Verfahren und vorrichtung zur herstellung eines thermoplastischen polyurethan-elastomers
US5202332A (en) 1991-08-07 1993-04-13 American Home Products Corporation Rapamycin analog as immunosuppressant
US5162333A (en) * 1991-09-11 1992-11-10 American Home Products Corporation Aminodiesters of rapamycin
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5932448A (en) * 1991-11-29 1999-08-03 Protein Design Labs., Inc. Bispecific antibody heterodimers
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
NZ251628A (en) 1992-03-30 1996-07-26 American Home Prod Aqueous insectable rapamycin solution; product containing concentrate and diluent solutions
US5489680A (en) 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
EP0672142B1 (en) 1992-12-04 2001-02-28 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
DE4301681C1 (de) * 1993-01-22 1994-10-20 Deutsche Aerospace Airbus Rohrverzweigung zwischen einer Luftleitung und einer Luftdusche
US5387680A (en) 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
EP0735893B1 (en) 1993-09-14 2008-11-26 Pharmexa Inc. Pan dr-binding peptides for enhancement of the immune response
AU689153B2 (en) 1993-11-08 1998-03-26 Cressy, Wayne Malcolm Head restraining device
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
SG64372A1 (en) 1993-12-17 1999-04-27 Novartis Ag Rapamycin derivatives
US5827690A (en) 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
US5362735A (en) 1994-02-23 1994-11-08 Smithkline Beecham Corporation Rapamycin derivatives
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5731168A (en) * 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
EP1281718A3 (en) 1995-11-10 2005-01-19 ELAN CORPORATION, Plc Peptides which enhance transport across tissues
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
DE69707033T2 (de) * 1996-03-05 2002-02-14 Hitachi, Ltd. Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten
AUPO390396A0 (en) 1996-11-29 1996-12-19 Csl Limited Novel promiscuous T helper cell epitopes
US5989591A (en) 1997-03-14 1999-11-23 American Home Products Corporation Rapamycin formulations for oral administration
US6982323B1 (en) * 1997-12-23 2006-01-03 Alexion Pharmaceuticals, Inc. Chimeric proteins for diagnosis and treatment of diabetes
IL139686A0 (en) 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
GB9814640D0 (en) 1998-07-06 1998-09-02 Fujisawa Pharmaceutical Co New use
US6015809A (en) 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
CA2341142A1 (en) 1998-09-02 2000-03-09 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US7109292B2 (en) 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001001137A1 (en) * 1999-06-30 2001-01-04 Children's Medical Center Corporation Fusion protein and uses thereof
DE19937656A1 (de) * 1999-08-13 2001-02-15 Aventis Behring Gmbh Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen
AU2001273194A1 (en) 2000-06-30 2002-01-14 Amgen Inc. B7-Like Molecules and Uses Thereof
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
WO2002010187A1 (en) * 2000-07-27 2002-02-07 Mayo Foundation For Medical Education And Research B7-h3 and b7-h4, novel immunoregulatory molecules
US7975021B2 (en) * 2000-10-23 2011-07-05 Clearplay, Inc. Method and user interface for downloading audio and video content filters to a media player
US6911311B2 (en) * 2001-01-04 2005-06-28 Myriad Genetics, Inc. Method of detecting protein-protein interactions
JP2004519233A (ja) * 2001-02-19 2004-07-02 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 免疫原性の低減された修飾された抗ｅｇｆｒ抗体
US20050215727A1 (en) * 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
IL150013A (en) * 2002-06-04 2007-06-17 Gil Hecht Swivel cutting tool
EP1539218A4 (en) * 2002-06-20 2007-08-22 Univ California COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCYTE ACTIVITY
US20040152105A1 (en) * 2002-09-06 2004-08-05 Cytos Biotechnology Ag. Immune modulatory compounds and methods
US7449300B2 (en) * 2002-11-21 2008-11-11 Mayo Foundation For Medical Education And Research Detection of antibodies specific for B7-H1 in subjects with diseases or pathological conditions mediated by activated T cells
US20050163772A1 (en) * 2003-06-16 2005-07-28 University Of Washington B7S1: an immune modulator
US7334413B2 (en) * 2004-05-07 2008-02-26 Rosemount Aerospace Inc. Apparatus, system and method for observing combustion conditions in a gas turbine engine
DE102004060403A1 (de) * 2004-12-14 2006-07-06 Trützschler GmbH & Co KG Vorrichtung in der Spinnereivorbereitung zur Speisung einer Mehrzahl von Füllschächten, insbesondere Mischer, mit Fasermaterial
US7694100B2 (en) * 2004-12-20 2010-04-06 Intel Corporation Managing system memory resident device management queues
BRPI0607579A2 (pt) * 2005-03-23 2009-09-15 Pfizer Prod Inc uso de anticorpo anti-ctla4 e indolinona para a preparação de medicamentos para o tratamento de cáncer
EP3130350A1 (en) * 2005-06-08 2017-02-15 Dana-Farber Cancer Institute, Inc. Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway
US20070039150A1 (en) * 2005-08-08 2007-02-22 Thomas David L Convertible furniture system comprised of modular convertible box frames and methods of forming various furniture configurations therefrom
KR100779170B1 (ko) * 2005-08-16 2007-11-23 학교법인 포항공과대학교 광양자테 홀 발광소자의 버트 커플링 방법
JP4730263B2 (ja) * 2005-09-21 2011-07-20 富士ゼロックス株式会社 画像処理装置の保守システム
US8241621B2 (en) * 2006-12-18 2012-08-14 Medistem Laboratories Stem cell mediated treg activation/expansion for therapeutic immune modulation
US20090142342A1 (en) 2006-12-27 2009-06-04 Johns Hopkins University B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
US7989173B2 (en) * 2006-12-27 2011-08-02 The Johns Hopkins University Detection and diagnosis of inflammatory disorders
CA2673659A1 (en) 2006-12-27 2008-07-10 The Johns Hopkins University Methods of detecting and diagnosing inflamatory responses and disorders by determining the level of soluble b7-h4
CN101399708B (zh) * 2007-09-28 2012-04-04 华为技术有限公司 一种建立网络性能模型的方法和设备
JP2011503104A (ja) * 2007-11-09 2011-01-27 カリフォルニア インスティテュート オブ テクノロジー 免疫調節化合物ならびに関連組成物および方法
US9005616B2 (en) * 2009-08-31 2015-04-14 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection

Similar Documents

Publication Publication Date Title
JP2011502954A5 (enExample)
RU2689160C2 (ru) Противораковая таргетная иммунотерапия с применением il-12
JP2020040969A5 (enExample)
TW202115128A (zh) FLT3L-Fc融合蛋白及其使用方法
Goldberg et al. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27
CN110437339A (zh) 一种以白介素15为活性成分的融合蛋白型药物前体
JP7004761B2 (ja) 癌治療のための改善された細胞組成物および方法
JP2022524018A (ja) Ｉｌ－１０バリアント分子ならびに炎症性疾患および腫瘍を処置する方法
CN108085340B (zh) 一种同时表达靶向cd19和cd20的car与pd1-cd28嵌合受体的慢病毒载体
JP7683932B2 (ja) ナチュラルキラー細胞を刺激するための組成物及び方法
JP6430949B2 (ja) Ｇｍ−ｃｓｆとｉｌ−４のコンジュゲート、組成物、ならびにそれに関連する方法
JP2014518632A (ja) ケモカイン−免疫グロブリン融合ポリペプチド、組成物、その作製および使用の方法
WO2021068196A1 (en) Methods of using il-33 protein in treating cancers
CZ20022843A3 (cs) Farmaceutický prostředek k léčbě nebo prevenci poškození jater, arthritidy a zánětlivých střevních onemocnění
JP7099956B2 (ja) がんの治療のためのｍｉｃａ／ｂアルファ３ドメインによるワクチン接種
CN116322785A (zh) 包含il-10的双细胞因子融合蛋白
TW201729829A (zh) 包含融合有免疫球蛋白Ｆｃ之介白素-７的用於預防或治療人類乳頭狀瘤病毒相關疾病的藥學組成物
JP2023071898A (ja) ＣＤ３００ｃの発現抑制剤または活性抑制剤を含む癌の予防または治療用薬学的組成物
JP2022512922A (ja) キメラ抗原受容体記憶様（ｃａｒｍｌ）ｎｋ細胞ならびにその産生および使用方法
JP2022527643A (ja) がん治療のための免疫療法
JP2024546938A (ja) マルチサブユニットサイトカインを含む二重サイトカイン融合タンパク質
Dell’Agnola et al. Clinical utilization of chemokines to combat cancer: the double-edged sword
JP4745224B2 (ja) 薬剤として有用なペグ化可溶性ｇｐ１３０二量体
AU2020343018B2 (en) Method for increasing lymphocyte count by using IL-7 fusion protein in tumors
CN114573709B (zh) 携带趋化因子受体且靶向msln抗原的car t免疫细胞的制备及其用途